VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+12.71%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$31.4B
AUM Growth
+$2.72B
(+9.5%)
Cap. Flow
-$46.7M
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
39.84%
Holding
1,057
New
52
Increased
556
Reduced
391
Closed
42
Top Buys
| 1 |
SSR Mining
SSRM
|
$190M |
| 2 |
Kinross Gold
KGC
|
$123M |
| 3 |
B2Gold
BTG
|
$94.9M |
| 4 |
Gold Fields
GFI
|
$80.9M |
| 5 |
Applied Materials
AMAT
|
$73.6M |
Top Sells
| 1 |
Sibanye-Stillwater
SBSW
|
$269M |
| 2 |
Newmont
NEM
|
$218M |
| 3 |
B
Barrick Mining Corporation
B
|
$218M |
| 4 |
Franco-Nevada
FNV
|
$121M |
| 5 |
Wheaton Precious Metals
WPM
|
$88M |
Sector Composition
| 1 | Materials | 59.5% |
| 2 | Technology | 13.57% |
| 3 | Healthcare | 5.48% |
| 4 | Financials | 3.32% |
| 5 | Consumer Discretionary | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Prospect Capital
PSEC
$1.34B
| $10.8M | 0.03% |
2,150,109
+216,579
| +11% | +$1.09M |
|
252
Teva Pharmaceuticals
TEVA
$21.7B
| $10.8M | 0.03% |
1,197,285
+316,201
| +36% | +$2.85M |
|
253
FS KKR Capital
FSK
$5.08B
| $10.7M | 0.03% |
673,754
+16,630
| +3% | +$264K |
|
|
BSX.PRA
254
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $10.6M | 0.03% |
+95,036
| New | +$10.6M |
|
255
Takeda Pharmaceutical
TAK
$48.6B
| $10.5M | 0.03% |
588,698
+27,839
| +5% | +$497K |
|
256
Main Street Capital
MAIN
$5.95B
| $10.5M | 0.03% |
354,932
+10,420
| +3% | +$308K |
|
257
Oracle
ORCL
$654B
| $10.4M | 0.03% |
174,851
-25,081
| -13% | -$1.5M |
|
258
Duke Energy
DUK
$93.8B
| $10.3M | 0.03% |
115,862
-1,873
| -2% | -$166K |
|
259
NextEra Energy, Inc.
NEE
$146B
| $10.2M | 0.03% |
147,204
-23,612
| -14% | -$1.64M |
|
260
VEON
VEON
$3.8B
| $10.2M | 0.03% |
323,360
+24,111
| +8% | +$760K |
|
261
JD.com
JD
$44.6B
| $10.2M | 0.03% |
130,846
+44,851
| +52% | +$3.48M |
|
262
GSK
GSK
$81.5B
| $10.1M | 0.03% |
213,975
-8,552
| -4% | -$402K |
|
263
The Mosaic Company
MOS
$10.3B
| $10.1M | 0.03% |
550,128
+10,019
| +2% | +$183K |
|
264
Honeywell
HON
$136B
| $10M | 0.03% |
60,822
-1,021
| -2% | -$168K |
|
265
Patterson-UTI
PTEN
$2.18B
| $10M | 0.03% |
3,509,491
-754,065
| -18% | -$2.15M |
|
266
Sixth Street Specialty
TSLX
$2.32B
| $9.84M | 0.03% |
571,762
+57,218
| +11% | +$985K |
|
267
Transocean
RIG
$2.9B
| $9.77M | 0.03% |
12,104,961
+1,414,373
| +13% | +$1.14M |
|
268
American Tower
AMT
$92.9B
| $9.7M | 0.03% |
40,109
-2,952
| -7% | -$714K |
|
269
Rithm Capital
RITM
$6.69B
| $9.61M | 0.03% |
1,208,548
-184,767
| -13% | -$1.47M |
|
270
Intuit
INTU
$188B
| $9.59M | 0.03% |
29,389
-4,512
| -13% | -$1.47M |
|
271
CVS Health
CVS
$93.6B
| $9.43M | 0.03% |
161,529
+23,005
| +17% | +$1.34M |
|
272
Enbridge
ENB
$105B
| $9.32M | 0.03% |
319,067
-16,646
| -5% | -$486K |
|
273
Jazz Pharmaceuticals
JAZZ
$7.86B
| $9.26M | 0.03% |
64,936
+7,446
| +13% | +$1.06M |
|
274
VanEck Intermediate Muni ETF
ITM
$1.95B
| $9.18M | 0.03% |
179,100
+159,945
| +835% | +$8.2M |
|
275
Nuveen Municipal Credit Income Fund
NZF
$2.36B
| $9.1M | 0.03% |
619,364
+5,074
| +0.8% | +$74.5K |
|